Article Details

Kerrisdale Capital Slams Altimmune (ALT) Stock in New Short Report - InvestorPlace

Retrieved on: 2024-02-13 20:21:39

Tags for this article:

Click the tags to see associated articles and topics

Kerrisdale Capital Slams Altimmune (ALT) Stock in New Short Report - InvestorPlace. View article details on hiswai:

Excerpt

In September 2023, the firm announced a short position in cannabis firm Tilray Brands (NASDAQ:TLRY). TLRY stock has fallen more than 35% since ...

Article found on: investorplace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up